Re: Are statins overprescribed? Why the risks and benefits are so complex / Pitavastatin
|
2
|
Resverlogix Corp.
|
Dec 04, 2018 08:44PM
|
Re: Question for Bear
|
2
|
Resverlogix Corp.
|
Jan 10, 2017 01:11PM
|
Re: 2 new upcoming presentations
|
2
|
Resverlogix Corp.
|
May 03, 2020 04:55PM
|
Re: The 3 inflection points: SSRA, Top-Line, Full Data
|
2
|
Resverlogix Corp.
|
Sep 10, 2018 09:26AM
|
Re: AACR
|
2
|
Zenith Epigenetics
|
Apr 09, 2019 11:36AM
|
Re: Actions Speak Louder Than Words
|
2
|
Resverlogix Corp.
|
Nov 20, 2016 01:28PM
|
Re: 2 new upcoming presentations
|
2
|
Resverlogix Corp.
|
May 03, 2020 04:59PM
|
Re: You're right 10bagr, you didn't sway me....
|
2
|
Resverlogix Corp.
|
Feb 01, 2019 04:05PM
|
Re: Vaccine
|
2
|
Resverlogix Corp.
|
Nov 17, 2020 09:46AM
|
Re: ESC Poster on BETonMACE Design and Baseline Data
|
2
|
Resverlogix Corp.
|
Sep 03, 2019 09:44AM
|
Re: Statistical Considerations
|
2
|
Resverlogix Corp.
|
Mar 09, 2018 10:05AM
|
Re: Patient Years & MACE rate Question
|
2
|
Resverlogix Corp.
|
Jul 11, 2019 09:00AM
|
June 7: Delivering Across the Blood Brain Barrier - Crossing the Final Frontier
|
2
|
BIOASIS TECHNOLOGIES INC
|
Apr 25, 2016 07:48AM
|
Re: Amgen cholesterol drug Repatha "Profound Regression", Dr. Nissen
|
2
|
Resverlogix Corp.
|
Nov 15, 2016 01:48PM
|
Re: Resverlogix Announces Participation at Premier Kidney, Alzheimer’s Disease and Cardiovascular Conferences
|
2
|
Resverlogix Corp.
|
Oct 28, 2018 08:33AM
|
Bioasis Acquires Phase 2 Ready Rare Orphan EGF Assets
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jun 21, 2022 08:08AM
|
Re: RVX 297 publication news from rndtbl from IV
|
2
|
Resverlogix Corp.
|
Oct 03, 2017 11:54AM
|
Re: Lowest volume in a long time?
|
2
|
Resverlogix Corp.
|
Dec 18, 2018 10:16AM
|
Bioasis Announces Allowances of Patent Applications in the U.S. and Europe Relating to xB3 Platform Technology and Key Therapeutic Indications
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jun 25, 2019 06:52AM
|
Re: AMRN Adcom
|
3
|
Resverlogix Corp.
|
Aug 08, 2019 09:40PM
|